investor
IP News

SCROLL DOWN
IP News
IP News.
’20 P62 LIGAND COMPOUND AND ER-PHAGY-PROMOTING USE THEREOF (KR, WO)
Date
2021-06-10
View
294

’20 P62 LIGAND COMPOUND AND ER-PHAGY-PROMOTING USE THEREOF (KR, WO)

 


Provided are a composition for promoting ER-phagy, a composition for maintaining ER homeostasis or reducing ER stress,

and a pharmaceutical composition for preventing and/or treating ER-stress-related diseases, which comprise a p62 ligand compound as an active ingredient.